# Effectiveness and Safety of Finerenone in Chinese CKD Patients Without Diabetes Mellitus

> **NCT06301022** · — · UNKNOWN · sponsor: **First Affiliated Hospital of Harbin Medical University** · enrollment: 90 (estimated)

## Conditions studied

- Chronic Kidney Diseases

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06301022
- **Lead sponsor:** First Affiliated Hospital of Harbin Medical University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-12-15
- **Primary completion:** 2024-10-31
- **Final completion:** 2024-12-31
- **Target enrollment:** 90 (ESTIMATED)
- **Last updated:** 2024-03-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06301022

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06301022, "Effectiveness and Safety of Finerenone in Chinese CKD Patients Without Diabetes Mellitus". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT06301022. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*